Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective | Pharmacology
Molecular mechanisms of opioid receptor-dependent signaling and behavior. - Abstract - Europe PMC
Kappa Opioid System in Nucleus Accumbens Drives Pain-Induced Negative Affect | Pain Research Forum
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives | SpringerLink
Kappa Opioid Receptor Distribution and Function in Primary Afferents
Inflammatory responses and inflammation-associated diseases in organs | Oncotarget
Kappa Opioid Receptor Distribution and Function in Primary Afferents
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
TRPV1 and MOR working in tandem: implications for pain and opioids use | Neuropsychopharmacology
κ-opioid receptor - Wikipedia
FF-2016-11 | Kappa-agonists for the treatment of MS
Nuclear Factor kappa-B Pathway – Inflammation's Role in Obesity
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists | Pharmacology